Egide: Project to tr
Egide: Project to transfer the listing of Egide's shares on the Euronext Growth market in Paris
June 01, 2022 12:00 ET | EGIDE
Bollène, June 1st, 2022 – 6 :00 pm(CET)Press ReleaseFor immediate release Project to transfer the listing of Egide's shareson the Euronext Growth market in Paris The Board of Directors of Egide...
EQUASENS (PHARMAGEST
EQUASENS (PHARMAGEST INTERACTIVE) : CA T1 2022 : +9,03% à 49,36 M€
May 12, 2022 12:10 ET | PHARMAGEST INTERACTIVE
Villers-lès-Nancy, le 12 mai 2022 - 18h00 (CET) COMMUNIQUE DE PRESSE CA T1 2022 : +9,03% à 49,36 M€Changement de nom effectif : le Groupe Pharmagest devient le Groupe Equasens L’Assemblée Générale...
EQUASENS_EN.jpg
EQUASENS (Pharmagest Interactive): Q1 2022 revenue: +9.03% to €49.36m
May 12, 2022 12:10 ET | PHARMAGEST INTERACTIVE
Villers-lès-Nancy, 12 May 2022 - 6:00 p.m. (CET) PRESS RELEASE Q1 2022 revenue: +9.03% to €49.36m Name change completed: Pharmagest Group becomes Equasens Group The Extraordinary General Meeting...
PHARMAGEST INTERACTI
PHARMAGEST INTERACTIVE : Résultat Net 2021 : +25,97% à 41,15 M€  et projet de changement de nom
March 25, 2022 14:20 ET | PHARMAGEST INTERACTIVE
Villers-lès-Nancy, le 25 mars 2022 – 19h00 (CET) COMMUNIQUE DE PRESSE Excellente performance, solide et profitableRésultat Net 2021 : +25,97% à 41,15 M€ Chiffre d’affaires :...
Pharmagest_Logo_2020_EN.png
Pharmagest Interactive: 2021 Net Profit: +25.97% to €41.15m and new name proposal for the Group
March 25, 2022 14:20 ET | PHARMAGEST INTERACTIVE
Villers-lès-Nancy, 25 March 2022 - 7:00 p.m. (CET) PRESS RELEASE High quality, strong and profitable growth2021 Net Profit: +25.97% to €41.15m Revenue: +12.41% to €193.07m All...
BlockLogo.png
Global Diversified Marketing Group Inc. Reports Record Revenue Growth for 2021
March 14, 2022 08:30 ET | Global Diversified Marketing Group, Inc.
ISLAND PARK, N.Y., March 14, 2022 (GLOBE NEWSWIRE) -- Global Diversified Marketing Group Inc., a Delaware corporation (the “Company”; OTC: GDMK), reported results today for its fiscal year ended...
ECC-1C-final choice_reduced.jpg
Ero Copper to Host Exploration Technical Session on March 10, 2022
March 08, 2022 07:30 ET | Ero Copper Corp.
VANCOUVER, British Columbia, March 08, 2022 (GLOBE NEWSWIRE) -- Ero Copper Corp. (TSX: ERO, NYSE: ERO) (the “Company”) is pleased to announce that it will host an exploration technical session on...
PHARMAGEST INTERACTI
PHARMAGEST INTERACTIVE : CA 2021 : +12,41% à 193,07 M€
February 04, 2022 12:04 ET | PHARMAGEST INTERACTIVE
Villers-lès-Nancy, le 4 février 2022 - 18h00 (CET) COMMUNIQUE DE PRESSE CA 2021 : +12,41% à 193,07 M€ +12,24% à 142,90 M€ pour la Division Solutions Pharmacie Europe avec une contribution...
Pharmagest_Logo_2020_EN.png
Pharmagest Interactive: 2021 revenue: €193.07m, up 12.41%
February 04, 2022 12:04 ET | PHARMAGEST INTERACTIVE
Villers-lès-Nancy, 4 February 2022 - 6:00 p.m. (CET) PRESS RELEASE 2021 revenue: €193.07m, up 12.41% +12.24% to €142.90m for the Europe Pharmacy Solutions Division, including significant...
ECC-1C-final choice_reduced.jpg
Ero Copper Files Technical Report for Boa Esperança Project
November 12, 2021 19:15 ET | Ero Copper Corp.
VANCOUVER, British Columbia, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Ero Copper Corp. (TSX: ERO, NYSE: ERO) (the “Company”) announces that it has filed the 2021 Technical Report regarding the optimized...